The Department of Health was alerted that Fresenius Kabi has Xylocaine with epinephrine presentations on shortage due to increased demand for the product and manufacturing delays and Pfizer has lidocaine with epinephrine presentations on shortage due to manufacturing delays.
You can read more about these shortages at:
Temporary Changes to CE Requirements (COVID-19) March 13, 2020
Today, the Florida Board of Osteopathic Medicine entered into emergency rulemaking and adopted Rule 64B15ER20-18, which waives the requirement for live, participatory attendance for certain continuing education courses for the 2018-2020 biennium, in accordance with Executive Orders 20-51 and 20-52 declaring a public health emergency pursuant to the spread of the Coronavirus Disease 2019 (COVID-19). Continue reading